The Osteoarticular Manifestations in Patients With Gitelman Syndrome

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how Gitelman Syndrome, a genetic condition that affects how the kidneys handle certain minerals, may lead to a specific type of joint problem called Calcium Pyrophosphate Deposition Disease (CPPD). The researchers are looking for patients who have both Gitelman Syndrome and CPPD to better understand how these conditions are connected. They will collect information about the patients’ symptoms and use medical imaging to see how CPPD affects the joints.

To participate in this trial, patients must have a confirmed diagnosis of Gitelman Syndrome. Unfortunately, those with other related conditions like Bartter Syndrome or hyperparathyroidism won't be eligible. If you or a family member qualify, you can expect to undergo screenings and tests to assess the impact of Gitelman Syndrome on joint health. This research aims to improve our understanding of these conditions and potentially lead to better treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients confirmed with Gitelman Syndrome
• Exclusion Criteria:
• • Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism